Form 4: Hologic CFO Karleen Oberton Reports Stock Transactions

Hologic's Chief Financial Officer, Karleen Oberton, has reported multiple transactions involving the company's stock, including the acquisition of restricted stock units and stock options.

Summary

• Karleen Oberton, the Chief Financial Officer of Hologic Inc., has filed a Form 4 detailing her recent transactions in the company's stock.
• On November 7, 2024, 1,161 shares were disposed of to cover tax obligations at a price of $79.29 per share.
• On November 8, 2024, another 12,598 shares were disposed of for tax obligations at a price of $78.76 per share.
• On November 11, 2024, Ms. Oberton acquired 9,447 restricted stock units.
• Also on November 11, 2024, she was granted an option to purchase 28,047 shares of common stock at an exercise price of $79.39.
• Following these transactions, Ms. Oberton directly owns 103,440 shares of common stock, which includes 41,121 restricted stock units/performance stock units that are deferred.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the transactions are routine and reflect standard executive compensation practices. The acquisition of stock units and options is a positive sign of alignment with company performance.

Positives

• The grant of 9,447 restricted stock units and 28,047 stock options to the CFO indicates continued alignment of management's interests with shareholders.
• The vesting schedule of the restricted stock units and stock options encourages long-term performance and retention.

Negatives

• The disposal of 1,161 and 12,598 shares to cover tax obligations may be seen as a slight reduction in the CFO's direct holdings, although this is a common practice.

Risks

• There are no specific risks mentioned in this document, but changes in executive holdings can sometimes be perceived negatively by the market.

Industry Context

This filing is a routine disclosure of insider transactions and is common for publicly traded companies. It provides transparency into the stock ownership of key executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for all publicly traded companies in the US, as mandated by the SEC.
• The transactions reported are typical for executive compensation, involving the vesting of restricted stock units and the granting of stock options.
• The vesting schedules of the restricted stock units and stock options are consistent with industry norms for executive compensation packages.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.
• The vesting of restricted stock units and stock options aligns management's interests with long-term shareholder value.

Key Dates

Keywords

Hologic, Karleen Oberton, stock transactions, Form 4, restricted stock units, stock options, insider trading, executive compensation